Wellness self-testing and telemedicine-based diagnostics are quickly growing trends. Both increasingly rely on the ability to quantify miniscule amounts of protein biomarkers from at-home collected samples. Platform technologies that enable ultrasensitive detection from small sample volumes and fit into existing workflows for sample collection, processing, and detection are needed to enable these highly-valued trends.
Spear Bio has developed a reagent-based technology for ultrasensitive protein detection. This novel solution offers significant benefits across the healthcare value chain.